missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ GluR7 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA520450
This item is not returnable.
View return policy
Description
A suggested positive control is human brain tissue lysate. PA5-20450 can be used with blocking peptide PEP-0567.
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. It is not certain if the subunit encoded by this gene is subject to RNA editing as the other 2 family members (GRIK1 and GRIK2). A Ser310Ala polymorphism has been associated with schizophrenia, and there are conflicting reports of its association with the pathogenesis of delirium tremens in alcoholics.
Specifications
| GluR7 | |
| Polyclonal | |
| Unconjugated | |
| GRIK3 | |
| 9630027E11; dJ1090M5.1 (glutamate receptor, ionotropic, kainate 3 (GLUR7)); EAA5; Excitatory amino acid receptor 5; GLR7; GluK3; GLUR7; Glur-7; GluR7-3; GluR7a; glutamate ionotropic receptor kainate type subunit 3; glutamate receptor; glutamate receptor 7; Glutamate receptor ionotropic, kainate 3; glutamate receptor subunit kainate subtype; glutamate receptor, ionotropic, kainate 3; Grik3 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 14807, 2899, 298521 | |
| Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 0.02% sodium azide | |
| B1AS29, P42264, Q13003 | |
| GRIK3 | |
| A 13 amino acid peptide near the amino terminus of the human Grik3. | |
| 100 μg | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction